DB
PAVM icon

Dmitry Balyasny’s PAVmed PAVM Stock Holding History

Dmitry Balyasny’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-30
Closed -$12K – 3162
2022
Q2 		$12K Buy
+30
New +$14.5K ﹤0.01% 2560

Other funds holding PAVM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Dmitry Balyasny's PAVM Position: Q3 2022 in Review

Dmitry Balyasny sold out of PAVmed (PAVM) in Q3 2022, closing a stake of 30 shares — an estimated $12K sold.

Dmitry Balyasny first reported a position in PAVM in Q2 2022 and held it in 1 quarter. The position peaked at $12K in Q2 2022. 70 funds tracked by Wall St. Rank hold PAVM as of Q3 2022.

  • Dmitry Balyasny reported no remaining PAVmed position as of Q3 2022 after selling out during the quarter.
  • Dmitry Balyasny sold 30 PAVmed shares in Q3 2022, an estimated $12K.
  • Dmitry Balyasny first reported a position in PAVmed in Q2 2022 and held it in 1 quarter.
  • Dmitry Balyasny's PAVmed position peaked at $12K in Q2 2022.
  • 70 funds tracked by Wall St. Rank held PAVmed as of Q3 2022.

Based on Balyasny Asset Management's 13F filing for Q3 2022, filed 15 Nov 2022.